HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (40) Citing Articles via Google Scholar Google Scholar Articles by Bush, D. A. Articles by Slater, J. M. Search for Related Content PubMed PubMed Citation Articles by Bush, D. A. Articles by Slater, J. M.

Proton-Beam Radiotherapy for Early-Stage Lung Cancer^*

^* From the Departments of Radiation Medicine (Drs. Bush, J.D. Slater, Moyers, and J.M. Slater), Diagnostic Radiology (Dr. Dunbar), and Pulmonary Medicine (Dr. Cheek), Loma Linda University Medical Center, Loma Linda, CA; and Klinik für Pneumologie (Dr. Bonnet), Zentralkrankenhaus Bad Berka GmbH, Bad Berka, Germany.

Correspondence to: David A. Bush, MD, Department of Radiation Medicine, Loma Linda University Medical Center, 11234 Anderson St, P.O. Box 2000, Loma Linda, CA 92354; e-mail: dbush{at}dominion.llumc.edu

Study objective: A prospective study was undertaken to assess the efficacy and toxicity of conformal proton-beam radiotherapy for early-stage, medically inoperable non-small cell lung cancer.

Design: Eligible patients had clinical stage I to IIIa non-small cell lung cancer and were not candidates for surgical resection for medical reasons or because of patient refusal. Patients with adequate cardiopulmonary function received 45 Gy to the mediastinum and gross tumor volume with photons with a concurrent proton boost to the gross tumor volume of an additional 28.8 cobalt gray equivalents (CGE). Total tumor dose was 73.8 CGE given over 5 weeks. Patients with poor cardiopulmonary function received proton-beam radiotherapy to the gross tumor volume only, with 51 CGE given in 10 fractions over a 2-week period.

Results: Thirty-seven patients were treated in the study from July 1994 to March 1998. Clinical staging of patients was as follows: stage I, 27 patients; stage II, 2 patients; and stage IIIa, 8 patients. Eighteen patients received a combination of protons and x rays, while 19 patients received proton-beam radiation only. Follow-up of evaluable patients ranged from 3 to 45 months, with a median of 14 months. Two patients in the proton and photon arm developed pneumonitis that resolved with oral steroids; otherwise, no significant toxicities were encountered. The actuarial disease-free survival at 2 years for the entire group was 63%; for stage I patients, disease-free survival at 2 years was 86%. Local disease control was 87%.

Conclusion: Preliminary results from this study indicate that proton-beam radiotherapy can be used safely in this group of patients. Disease-free survival and local control appear to be good and compare favorably with published reports utilizing conventional photon irradiation.

Key Words: inoperable • lung cancer • proton • radiotherapy

This article has been cited by other articles:

				T. Ogata, T. Teshima, K. Kagawa, Y. Hishikawa, Y. Takahashi, A. Kawaguchi, Y. Suzumoto, K. Nojima, Y. Furusawa, and N. Matsuura Particle Irradiation Suppresses Metastatic Potential of Cancer Cells Cancer Res., January 1, 2005; 65(1): 113 - 120. [Abstract] [Full Text] [PDF]

				W. R. Smythe Treatment of Stage I Non-small Cell Lung Carcinoma Chest, January 1, 2003; 123(1_suppl): 181S - 187S. [Abstract] [Full Text] [PDF]

				R. B. Bonnet, D. Bush, G. A. Cheek, J. D. Slater, D. Panossian, C. Franke, and J. M. Slater Effects of Proton and Combined Proton/Photon Beam Radiation on Pulmonary Function in Patients With Resectable but Medically Inoperable Non-small Cell Lung Cancer Chest, December 1, 2001; 120(6): 1803 - 1810. [Abstract] [Full Text] [PDF]